ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s stock price fell 5.3% during mid-day trading on Monday . The stock traded as low as $1.21 and last traded at $1.24. 374,328 shares traded hands during mid-day trading, an increase of 1,742% from the average session volume of 20,327 shares. The stock had previously closed at $1.31.
ImmunoPrecise Antibodies Stock Performance
The stock has a 50 day simple moving average of $1.71 and a 200-day simple moving average of $1.82.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.
ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
- Only 500 people today…
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
